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DIFFERENTIAL EFFECT BETWEEN
THESE TISSUES RELATED TO
DRUG AND GAMMA-RAY FRAC-
TIONATION SCHEMES. A. WAM-
BERSIE, H. MAISIN, M. VAN DER PERRE and
M. R. SMOES, Radiotherapy Unit, Tumour
Centre, Capucienenvoer, Louvain.
Combination of irradiaton and 5-FU was
proved clinically to be of interest in the
treatment of malignant tumours, in parti-
cular of the gastrointestinal tract. The
possibility of achieving a differential effect
between several tissues as a function of
fractionation of drug and irradiation (60Co)
was investigated.
Three biological criteria were studied in
mice: intestinal death (LD50/5) after abdomen
irradiation, bone marrow death (LD50/30)
after total body irradiation and the response
of a Landschuts tumour grown in a solid or
ascitic form. Total 5-FU doses of 75 or
150 mg/kg were administered i.p.
For LD50/5, 5 equal daily injections, on
Day 5 to 1 before irradiation, were more
efficient than a single injection 3 days before
irradiation. The contrary was observed for
LD50/30, suggesting a differential effect
between these 2 normal tissues related to
5-FU fractionation. The first results on
Landschuts tumours are similar to those
observed for LD50/5. On the investigated
tissues, 2 i.p. injections of 5-FU 18 and 9 h
before irradiation were less efficient.
D2-D1 was studied for an interval of31 h,
24 h and 4 days between the fractions of
60Co. For LD50/5 and LD50/30, D2-D1 was
not significantly reduced after 5 injections of
5-FU (75 mg total dose) taking into account
the reduction of size of the gamma fractions.
RADIATION AND DRUGS; VARIOUS
MECHANISMS OF INTERACTION.
L. M. VAN PUTTEN, Radiobiological Institute
TNO, Rijswijk.
Various mechanisms were studied in
which combination of radiation and drugs
could be more effective than adding more
radiation, and model systems were developed
to identify these mechanisms.
Interaction ofdrugs and radiation leading
tosensitization couldoccur through oneofthe
following mechanisms: (a) interaction due to
presence of the drug during exposures, (b)
interference with repair, (c) differential
effectiveness of drugs on tumour and host
cells through different degrees of cell kinetic
response to radiation (recruitment) in these
2 systems.
The mechanism oftype (a) was studied for
hypoxic sensitizers on a poorly reoxygenating
mouse osteosarcoma. It was found that
metronidazole and Ro-07-0582 had a more
than additive effect on this tumour when
combined with fractionated radiotherapy.
Mechanisms oftype a, b and c were studied in
normal mouse haemopoietic stem cells.
None of the agents tested was effective by
mechanism (a) on well oxygenated haemo-
poietic stem cells. For 5-FU and vinblastine
an effectiveness by mechanism (b) could be
confirmed and many drugs were effective by
mechanism (c). However, the limitation of
the analysis to crmal tissue made it im-
possible to identify a gain of effectiveness on
tumours compared with normal tissues.
It seems unlikely that all clinical tumours
may be influenced equally by combination
therapy and it will be necessary to identify
the various categories of tumour radiation
resistance in order to apply the optimal type
of combination therapy.
Work supported under contract NO1-
CM-53763 by the National Cancer Institute
USA.
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RADIOPROTECTIVE EFFECT OF
WR 2721 IN COMBINED INJURED
MICE (X-IRRADIATION AND SKIN
LESION). F. VERSPOHL and 0. MESSER-
SCHMIDT, Laboratorium fur Experimentelle
Radiologie, Neuherberg bei Miinchen.
The protective effect ofthe thiophosphate
compound WR 2721, resulting in a reduction
of radiation lethality in mammals, is well
known. The effectivity of protective agents
afterinfliction ofirradiation and an additional
wound or other kind of stress on animals has
not yet been investigated.
In our investigations female mice were
given x-irradiation and an open dorsal
wound was made 2 or 8 days after irradiation.ABSTRACTS OF PROFFERED PAPERS 755
The combination of the injuries caused a
greatly increased lethality in comparison with
that due to irradiation alone. Our results
also revealed a significant effect in combined
injured mice, though it was not as distinct as
after irradiation only.
INFLUENCE OF CYSTEAMINE OR
CYSTAMINE ON RADIATION LATE
EFFECTS IN C57BL/6 MICE. D. J.
MEWISSEN, J. H. RUST and J. HAREN,
Department ofRadiobiology, Free University
of Brussels.
Late sequelae of sublethal whole body
irradiation were investigated in various
groups of C57 BL/6 mice, assigned to sham
irradiated control groups and to matching
experimental groups pretreated with cyste-
amine or cystamine. Several irradiation
schedules were used, including a single dose
of 280, 440 or 550 rad and 2 successive doses
at a 7-day interval, of 140, 220 or 280 rad.
Complete results indicate that the tumour
spectrum in control mice is modulated by
whole body radiation in a complex non-
monotonic incidence-dose relationship. Fol-
lowing the highest dose levels the tumour
yield tended to decrease. The relative
incidence ofsome tumour types was diversely
affected by radiation. In groups of animals
pretreated with cysteamine or cystamine,
tumour spectra were modulated primarily as
a function of age specific incidence as
observed in matching controls.
This work was performed under Euratom
contract.
EFFECT OF60CO-y-IRRADIATION ON
THE MIXED DISULPHIDES OF
RADIOPROTECTOR MEG IN SPLIT-
TING WITH ENZYMES OF RAT
LIVER CYTOPLASM. M. HORVATH and
J. HOLLAND, National Institute of Oncology,
Budapest.
According to the theory of Eldjarn and
Pihl, mixed disulphides formed by radio-
protective aminothiols and protein SH groups
can be split by enzymes in the organism and
the native structure of proteins thus
restored.
In our experiments mixed disulphides of
MEG and albumin/haemoglobin were split by
soluble enzyme fraction of rat liver homo-
genate (cytosol). The splitting is performed
by small molecules; dialysed cytosol has no
effect, neither has the suspension of particles
ofmitochondria. Upon 60Co-y-irradiaton the
mixed disulphide bridge is stabilized and is
more resistant to splitting at doses in the
Mrad range. Increased resistance up to
700% with albumin-MEG and 160% with
haemoglobin-MEG mixed disulphide was
observed compared withunirradiated control.
INTERACTION OF X-IRRADIATON
AND DRUGS ON THE ACTIVITY
OF MEMBRANE BOUND ENZYMES.
A. W. T. KONINGs and E. B. DRIJVER,
LaboratoTy of Radiopathology, State Uni-
versity of Groningen.
The study of the interaction of radiation
and drugs on the level of membrane depen-
dent enzyme activity might yield information
concerning the nature and meaning of
radiation induced membrane damage. The
effects of some pharmacological agents on
the activities of membrane bound enzymes
have been inv-estigated in normal and
o-tocopherol depleted mice. Special atten-
tion has been given to the plasma-membrane
enzyme, alkaline phosphatase. This enzyme
showed a decreased activity in the ax-toco-
pherol depleted liver compared with the
normal liver. Total body x-irradiation of
650 rad gave a clear rise in enzyme activity of
the normal liver and only a slight increase in
the liver of the diet mouse. Intraperi-
toneally injected Novocaine or cysteamine
enhanced the radiation induced enzyme
activity in normal but not in the cx-tocopherol
depleted liver. These results suggest a
regulation of the enzyme activity by the
micro-environment in the membrane. Both
irradiation and drugs might have given a
relief of constraint, being associated with an
increased enzyme activity. The inability of
the drugs to enhance the radiation induced
alkaline phosphatase in the diet liver, points
to a limited amount of enzyme molecules in
the plasma membrane of the ae-tocopherol
depleted animals.
COMBINED RADIATION AND DRUG
TREATMENT OF THE B16 MELA-
NOMA. J. STANLEY, G. G. STEEL and
R. P. HILL, Biophysics Department, Institute
of Cancer Research, Sutton.
Using the lung colony assay, studies have
been made of the survival of clonogenic cells
following treatment of B16 melanoma with